Yellow Tea (Camellia sinensis)
Yellow tea (Camellia sinensis) is a lightly oxidized tea containing high concentrations of epigallocatechin gallate (EGCG), comprising approximately 50% of its total catechin profile. Current evidence is limited to in vitro and chemical profiling studies, with EGCG hypothesized to exert antioxidant effects by scavenging reactive oxygen species and modulating oxidative stress pathways.

Origin & History
Yellow tea is a lightly fermented tea produced from Camellia sinensis leaves, originating from China where it undergoes a unique 'men huan' (yellowing) process involving steaming or pan-firing followed by controlled piling and drying. This partial oxidation process creates its characteristic mellow flavor and yellow liquor, distinguishing it from unfermented green tea.
Historical & Cultural Context
Yellow tea has historical roots in Chinese traditional medicine dating back to the Ming Dynasty (14th-17th centuries), valued as imperial tribute from regions like Hunan and Sichuan. It features in Traditional Chinese Medicine systems for harmonizing qi, supporting spleen health, and reducing inflammation.
Health Benefits
• No human clinical trials identified - evidence limited to chemical profiling • Contains high levels of EGCG catechins (~50% of total catechins) with potential antioxidant properties (in vitro evidence only) • Rich in polyphenols including gallic acid and flavan-3-ols (chemical analysis data only) • Contains theanine and other amino acids that may support relaxation (traditional use, no clinical evidence) • Historically used in Traditional Chinese Medicine for digestion and detoxification (traditional evidence only)
How It Works
EGCG in yellow tea inhibits reactive oxygen species (ROS) by donating hydrogen atoms to free radicals, a process measured in vitro via DPPH and ORAC assays. Gallic acid and flavan-3-ols may inhibit pro-inflammatory enzymes such as cyclooxygenase-2 (COX-2) and modulate NF-κB signaling pathways based on cell culture data. These mechanisms are well-characterized in green tea research and are extrapolated to yellow tea due to shared catechin composition, but have not been confirmed in human pharmacokinetic studies.
Scientific Research
No human clinical trials, RCTs, or meta-analyses for yellow tea were identified in the research. Available data focuses exclusively on chemical profiling and in vitro bioactivities rather than human health outcomes.
Clinical Summary
No human clinical trials specifically investigating yellow tea have been identified in the published literature as of 2024. Mechanistic insights are extrapolated from extensive green tea EGCG research, where randomized controlled trials (n=30–1000+) have documented antioxidant and metabolic effects. Chemical profiling studies confirm yellow tea's polyphenol content, including gallic acid and flavan-3-ols, but bioavailability and efficacy in humans remain unstudied. The evidence base is therefore rated as preliminary and insufficient to support therapeutic claims.
Nutritional Profile
Yellow tea (Camellia sinensis) prepared as a beverage (standard 2g/200ml infusion) contains negligible macronutrients: <2 kcal per cup, trace protein (0.1–0.3g), no fat, and minimal carbohydrates (<0.5g). The defining bioactive profile centers on polyphenols: total catechins estimated at 80–120mg per cup, with EGCG (epigallocatechin gallate) comprising approximately 50% of total catechins (~40–60mg/cup), followed by EGC (~15–20mg), ECG (~10–15mg), and EC (~5–10mg). Gallic acid is present at approximately 5–15mg/cup. Total polyphenol content is estimated at 150–250mg GAE (gallic acid equivalents) per cup, somewhat lower than green tea due to the mild yellowing ('men huan') oxidative processing which partially degrades catechins. Theanine (L-theanine) content is approximately 6–20mg per cup, comparable to green tea, contributing umami character and potential neuromodulatory effects. Caffeine content is moderate at approximately 20–40mg per 200ml serving. Minerals detectable in infusion include potassium (10–20mg/cup), manganese (0.3–0.5mg/cup — a meaningful contributor toward the 2.3mg AI), fluoride (~0.2–0.4mg/cup), and trace magnesium and zinc. Vitamin K is present at low levels (~1–2µg/cup). Bioavailability note: catechin absorption from tea infusion is limited (approximately 1.5–4% of ingested dose reaches systemic circulation) due to colonic degradation and limited intestinal transport; co-consumption with food further reduces absorption by up to 25–30%. Theanine is well-absorbed orally (~95% bioavailability). Data derives primarily from chemical profiling studies of Chinese yellow teas (Junshan Yinzhen, Huoshan Huangya); significant batch and preparation variability exists.
Preparation & Dosage
No clinically studied dosage ranges for yellow tea have been established due to absence of human trials. Chemical analyses show EGCG content at approximately 50% of total catechins, but this has not been linked to dosing protocols. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Green tea extract, L-theanine, White tea, Oolong tea, EGCG
Safety & Interactions
Yellow tea contains caffeine, and excessive consumption may cause insomnia, anxiety, elevated heart rate, or gastrointestinal discomfort, consistent with other Camellia sinensis teas. High-dose EGCG supplementation (above 800 mg/day) has been associated with hepatotoxicity in green tea extract studies, though beverage-form consumption at typical doses is generally considered safe. Yellow tea may interact with anticoagulants such as warfarin due to vitamin K content and may reduce iron absorption when consumed with meals. Pregnant individuals should limit caffeine intake to under 200 mg/day; no yellow tea-specific pregnancy safety data exists.